InnoPharmax, Inc.
Verified IntelINNOPHARMAX develops oral new dosage form new drugs for further clinical development and commercialization, utilizing core drug delivery technology platforms OralPAS®, OralPAS Pro®, and MUCR. We are committed to improve the safety and efficacy of currently available drugs, and provide superior and cost effective medical options.
INNOPHARMAX develops oral new dosage form new drugs for further clinical development and commercialization, utilizing core drug delivery technology platforms OralPAS®, OralPAS Pro®, and MUCR. We are committed to improve the safety and efficacy of currently available drugs, and provide superior and cost effective medical options.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Public Company
- Founded
- Undisclosed
- Employee Bracket
- 11-50
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 11492 Taipei
- City
- —
- Region / State
- —
- Postal Code
- —
- Country
- Taiwan
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for InnoPharmax, Inc..